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Automatic diagnosis of the SleepApnea-Hypopnea Syndrome (SAHS) has become an important area of research due to the growing
interest in the field of sleep medicine and the costs associated with its manual diagnosis. The increment and heterogeneity of the
different techniques, however, make it somewhat difficult to adequately follow the recent developments. A literature review within
the area of computer-assisted diagnosis of SAHS has been performed comprising the last 15 years of research in the field. Screening
approaches, methods for the detection and classification of respiratory events, comprehensive diagnostic systems, and an outline of
current commercial approaches are reviewed. An overview of the different methods is presented together with validation analysis
and critical discussion of the current state of the art.
1. Clinical Background
Sleep Apnea-Hypopnea Syndrome (SAHS) is one of the
most common disorders affecting sleep, characterized by the
repeated occurrence of involuntary episodes of total or partial
reduction in patient’s respiration during the night [1]. Several
studies have been carried around the world during the last
years, which estimate that the prevalence of SAHS is between
the 3% and the 7% of the adult population [2, 3].
Patients suffering from SAHS present involuntary respi-
ratory pauses that repeats throughout the night.The duration
of these nocturnal respiratory events (from now on apneic
events) is variable and it depends on the concrete patient;
however to be clinically significant, the duration must be of
at least 10 seconds, normally not exceeding the 2 minutes.
Common duration of the apneic event, though, is usually
about 20 to 40 seconds. One main distinction can be made
within the apneic event attending to the associated reduction
in the airflow. For that purpose the baseline breathing can
be determined which is defined as a period of regular
breathing with stable oxygen levels [4]. Thus, in a broad
sense a hypopnea is defined as a respiratory pause meeting
the duration criteria with an associated reduction around
30–50% with respect to the baseline breathing. The exact
definition however highly depends on the concrete reference
[5]. In the case of an apnea the associated reduction is more
pronounced reaching about 90% or even total breathing ces-
sation. Last standard definitions by the American Academy
of Sleep Medicine (AASM) can be consulted in [6].
Respiratory pauses associated with the presence of an
apneic event are also usually accompanied by a drop in
the oxygen saturation levels. This fall is proportional to
the causing airflow reduction. As a consequence, the lack
of oxygen in arterial blood usually triggers an autonomic
response increasing the alertness level of the individual which
often causes neurophysiological awakening [7, 8]. These
associatedmicroarousals break up the normal sleep structure
preventing a refreshing rest. Therefore daytime sleepiness is
usual in apneic patients, impacting on their social, working,
and family life. In addition, one of the main problems of
this disease is that patients are usually unaware of their own
symptoms. That contributes also to the fact that most of the
SAHS patients are currently underdiagnosed [9].
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In 1983 Guilleminault et al. [10] described cardiac
arrhythmias and behavior disorders related to SAHS. This
description was followed by several reports searching for
cardiac arrhythmia, hypertension, cerebrovascular accidents,
and sudden death as sequels of SAHS. Nowadays SAHS is
associated with an increasing risk of suffering cardiac and
cerebral infarct, high arterial pressure, arrhythmias, and, in
general, several dysfunctions of the cardiorespiratory system
[11–14].
The standard diagnostic procedure to determine the
presence of SAHS requires a polysomnographic test to be
done during the night. This test is normally carried out
in the sleep units of the medical centers, and it involves
the recording of several physiological signals during the
night, both respiratory and neurophysiological.The resulting
recording, namely, polysomnographic recording or PSG, is
then visually analyzed offline by the medical specialists.
From this analysis, one important derived measure is the
Apnea-Hypopnea Index (AHI), which is calculated as the
number of apneic events (either apnea or hypopnea) present
in the PSG per hour of sleep and is used as objective
indicator to quantify the SAHS severity in a subject. This
index is also used as fundamental measure involved in the
diagnosis of the syndrome in which cut-off values ranging
between 5 and 15 are usually established as thresholds above
which the AHI is regarded as clinically relevant in the
diagnostic procedure [9]. Assessment of the AHI implies
manual revision of the PSG recording, considering all evi-
dences present in the respiratory signals and interpreting
them according to contextual information of remaining PSG
signals.
Given the complexity of the scoring process, mainly
because of the length of a full-night PSG recording, as well as
the amount and the diversity of signals involved, the analysis
of the PSG represents a big cost both in time and in effort for
the clinician.This high cost associated with themanual visual
review of the PSG can eventually degenerate into quality loss
of the analysis due to the accumulated tiredness throughout
the revision and because of the complexity of the task itself.
From the point of view of hospital’s administration, it may
also represent a waste of the personnel resources who could
be dedicated to other affairs. In general the consequence is a
saturation of the current sleep units, not being able to support
the demand for the analysis. Eventually, all the previous
causes an elevation in the economic costs associated with the
diagnosis of SAHS.
In this regard, the development of systems that automate,
at least in part, the analysis of the PSG represents great saving
in terms of time, money, and effort, facilitating the clinician’s
task in a great extent and optimizing his/her time. Indeed, in
the ideal scenario of a system being able to completely—and
correctly—perform the automatic analysis of the PSG, the use
of supporting tools for the diagnosis would help the scorer to
focus his/her attention only on the real relevant information
(e.g., the AHI). Indeed, ultimately the physician’s task could
be reduced to the sole task of checking and/or confirming the
results of the computer analysis.
2. Motivation
In a revision made in 2000 by Penzel and Conradt about
computer systems for the recording and the analysis of the
sleep, there was a reference to the four tasks that a system of
such characteristics should fulfill [15].
The first task is that systems should replace conventional
paper chart recorders.The objective is to save paper andmin-
imize archiving space requirements without losing the raw
data. The second task is documentation. With the computer-
based system, a technician should be able to enter and store all
necessary notes and observations made during the nocturnal
recording.The third task is supporting the evaluation of sleep
and cardiorespiratory functions. In this regard, an automatic
sleep scoring system should use its computational power to
support the PSG scoring task. Specifically, according to [15]
the system should be able to analyze electroencephalography
(EEG), electrooculography (EOG), and electromyography
(EMG) in terms of sleep stages; respiration, snoring, and
oxygen saturation (SaO
2
) for the diagnosis of sleep related
breathing disorders; and EMG tibialis in terms of limbmove-
ment disorders. Other parameters recorded in a sleep labora-
tory, such as body temperature, electrocardiography (ECG),
blood pressure, capnography, and esophageal pressure (Pes),
may require additional analysis. On the other hand, the
system should support visual evaluation as an alternative
to automatic analysis, and it should allow editing of the
results of the automatic scoring. The fourth task is reporting.
The computer-based system should help in the generation
of a final report containing the relevant information for the
diagnosis, and it should include an advanced filing system to
archive the report as well as the data in a structured way.This
will allow the sleep laboratory to keep track of patients and to
recall reports when needed for revision [15].
Nowadays almost nobody doubts that tasks one, two, and
four are quite covered already, since the incorporation of the
Health Management Information Systems into the hospitals,
including the sleep labs, is already a reality. It is regarding
the task number three, the one relative to the capabilities
of computer programs to perform the automatic analysis of
the PSG, however, where these systems still present shortages
and, as a consequence, where most of the research effort is
concentrated at present.
The emerging importance of the sleep medicine during
the last years has also contributed to an increasing demand
in the diagnosis of SAHS and its associated treatment. As a
consequence, the number of PSG studies has also increased,
which, in the lack of a simpler and more precise test, still
today continues to be the only standard procedure for the
diagnosis of SAHS. Portable monitoring has emerged in the
last years, aiming at mitigating the problematic effects of
the limited resources at the hospital centers. It has been
mentioned already, however, that visual analysis of the PSG
is a costly, tedious, and time-consuming task with an impact
on the working life of the medical specialists, who have to
devote great part of their time to the scoring of the night
registrations. With this precedent, the interest grows toward
the development of automatic systems to aid the physician in
the diagnosis of SAHS.
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These two factors (increasing demands in the analysis and
the still present shortages of the current analysis systems)
have favored an increment of the research activity in the
field in the last years. As a consequence, research in the
development of computer methods for the analysis of sleep,
and specifically for the diagnosis of SAHS, is today an
important open area interest. The increasing number of
research publications (and the lack of comprehensive reviews
in this respect) demands an integrative effort to be done.This
hasmotivated the authors of this paper to perform a literature
review, trying to group together the most recent research
efforts in this respect and to make them available as a single
resource to serve the scientific community.
This review is thus intended to perform an update of
the current state of the art in the field of computer-aided
diagnosis of SAHS. The aim especially is to cover recent
approaches and advances in the field during approximately
the last 15 years. Ultimately it is the intention of the authors
with this review to provide the interested reader with a useful
resource in order to keep track of themost recent advances in
the field.
3. Methods
This paper is aimed at covering approaches in the field
of SAHS which are to some extent supported by auto-
matic computer-based processes helping the diagnosis. This
includes as well mathematical models and/or algorithm
descriptions that can be eventually implemented into a
computer program. Bibliography not assessing the evaluation
of the presence of SAHS in the subject will not be considered
(will be excluded from the evaluation). This includes a con-
siderable number of works related to computer approaches
to support sleep analysis but not specifically related to SAHS
(e.g., automatic sleep scoring) which are not considered here.
On the other hand, to keep the review attainable, the focus
will be constrained to methods involving analysis of the
respiratory function in accordance with the current standard
clinical procedures. In this respect, the last version of the
AASM manual for scoring of sleep and associated events is
considered as in [6]. That means approaches must operate
using, at least, a subset of the PSG signals which are proposed
in the AASM manual for such purposes (see section VIII,
Respiratory Rules in [6]). This rules out approaches relying,
for example, on the use of questionnaires, clinical prediction
models, and/or analysis of nonstandard biomedical signals
for the diagnosis of SAHS such as the ECG or the EEG.
Studies in which the only computer support refers to the
recording and/or the visualization of the digital signals are
not considered under this review. Therefore studies referring
to devices in which diagnosis is exclusively based on visual
human scoring are also omitted from the analysis. Finally,
although some references may be included, it is not the
objective of this paper to cover SAHS treatment, including
devices or methods dealing with Continuous Positive Airway
Pressure (CPAP).
Given the previous context, analysis of the relevant bibli-
ography has been derived in part from our own experience
and research in the field, plus literature search which has
been carried out using different well-known search engines
including ScienceDirect, IEEE explorer, PubMed, andGoogle
Scholar. Search terms included combinations of the words
“apn(o)eic,” “apn(o)ea,” “intelligent,” “OSAS,” “OSAHS,”
“OSA,” “SAHS,” “monitoring,” “diagnosis,” “automatic,”
“computer,” and “analysis.” That returned a first group of
works which was subsequently redefined by careful revision
of the corresponding abstracts in order to filter out studies
nonrelevant for the purposes of this review. The resulting
group of selected works was, in addition, supplementary
expanded by a thorough search within the reference lists of
the eligible studies, and the relevant studies were selected and
included in the analysis.
With regard to the time coverage, the authors placed
special emphasis on covering the most recent published
literature over the last 15 years (from January 1999 up
to December 2013) although some references to preceding
works may be present when considered relevant or for intro-
ductory purposes. Only peer-reviewed literature in English
was included in the study. In general, for all the methods
analyzed within this review, discussion is based exclusively
on the data published in the corresponding works. Also,
when analyzing literature regarding commercial devices, data
available from manufacturers on their websites, in product
brochures, or published in non-peer-reviewed journals is not
considered as well.
To structure the discussion, approximations analyzed
under this review are organized into several categories as
described below. For each category the related works are
introduced following a descriptive approach and, at the end
of each section, a summary table is presented for quick ref-
erence that contains an overview of the different approaches
analyzed in the corresponding category. On the other hand,
in an attempt to provide quantitative data for validation
and comparison purposes, a second summary table within
each section is provided. Structure of these tables may
slightly vary from section to section according to the topic
of the discussion and therefore specific description of their
related structure is provided in the corresponding section.
Nonetheless it is common for all the validation tables that
the widely used measures of sensitivity and specificity (when
available in the referenced study) are used to characterize
the results. In this respect, it is worth saying that if several
results are reported in the referenced study (e.g., due to
different configurations of the computer method), the best
performance will be always selected as the general criterion.
The best performance is here interpreted as the point that
maximizes the following value: (sensitivity + specificity)/2.
This is equivalent to the area under the corresponding ROC
curve with one-operation point. It is therefore an optimistic
criterion for which it corresponds to the best operation point.
Organization of the review is structured as follows. In
subsequent Section 4, general analysis of the current state
of the art in the field of automatic diagnosis of SAHS is
performed. In order to structure the different approxima-
tions, the discussion is divided into different subsections.
Section 4.1 comprises screening approaches performing over
the biomedical signals recorded in the PSG. Section 4.2
deals with approximations in which detection of the apneic
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event is performed individually throughout the recording.
This section is further divided according to the reference
used for the detection. Specifically approximations are struc-
tured comprising processing of the pulse oximetry signal
(Section 4.2.1), alternative single-channel respiratory signals
(Section 4.2.2), and multichannel analysis of the respiration.
Section 4.3 is dedicated to approximations specialized in the
classification of the apneic event according to its origin (i.e.,
central, obstructive, or mixed). In the last part of Section 4
(Section 4.4), the analysis is focused on comprehensive
approaches covering respiration as well as neurophysiological
information.
The analysis is expanded in Section 5 to briefly dis-
cuss validation results from publications regarding com-
mercial approximations. General discussion is performed
in Section 6 which will carry out a critical analysis of the
different approximations described throughout this review.
Finally, concluding remarks are assessed in Section 7.
4. State of the Art in the Computer-Based
Diagnosis of SAHS
Throughout this section the objective of the discussion is to
reflect the current research state on the different methods
and techniques developed for the computer assisted diag-
nosis of SAHS. As stated above, in order to structure the
discussion, the different approximations have been divided
into different subsections and four well-differenced types
of approximations can be distinguished, namely, approaches
comprising SAHS screening approaches, methods for the
individual detection of the apneic events,methods focused on
the classification of the apneic event type, and comprehensive
approaches.
4.1. Screening Approaches for SAHS Estimation. Due to the
complexity and the elevated costs associated with the PSG
test, much of the current research interest in the diagnosis
of SAHS is focused on reducing the necessity of (at first)
submitting the patient to conduct night-attended in-hospital
monitoring. For that purpose, the resulting approximations
are normally aimed at substituting PSG outcomes, for exam-
ple, AHI, by means of the calculation of a simpler supple-
mentary measure which can be interpreted as a preliminary
evaluation of SAHS severity and ismeant to fulfill a screening
function. In this respect, computer methods targeting a
screening task comprise, as a minimum, the classification of
the subject either as normal or as apneic. Some methods, in
addition,may also attempt to predict (through regression) the
associated severity index. Many approaches can be found in
the literature with such characteristics, but, as stated in the
Introduction, we here focus on methods that, to some extent,
involve the recording and/or the subsequent analysis of subset
of the respiratory signals contained in the PSG.
An overview of the different screening approaches ana-
lyzed throughout this section is shown in Table 1. Subse-
quently, Table 2 summarizes validation data of the corre-
sponding approaches. For interpretation of the contents of
Table 1: Summary of SAHS screening approaches.
Source Method References
Oxygen saturation
Counting on the
number of
desaturation events
Netzer et al. [16]
Time spent below
90% Netzer et al. [16]
Expert systems Daniels et al. [17]
Delta-index
Le´vy et al. [18], Olson et
al. [19], and Magalang et
al. [20]
Spectral analysis
Zamarro´n et al. [21, 22],
Hua and Yu [23], and
Morillo et al. [24]
Nonlinear methods
(CTM, LZ, and
ApEn)
A´lvarez et al. [25, 26],
Hornero et al. [27], and
del Campo et al. [28]
Machine learning
Victor-Marcos et al.
[29–33], A´lvarez et al.
[34, 35], and El-Solh et
al. [36]
Airflow
Spectral analysis Gutierrez-Tobal et al.[37]
Nonlinear methods
(CTM, LZ, and
ApEn)
Gutie´rrez-Tobal et al.
[38]
Hilbert-Huang
decomposition
Caseiro et al. [39],
Salisbury and Sun [40]
Table 2, description of the different columns is done as
follows.
Column 1 in Table 2 indicates the bibliographic reference.
Columns 2 to 5 include study population details, respectively,
the database identification, the number and gender of the
participants, the age of the population, and the reference
severity index. Columns 6 and 7 describe the gold standard
to establish the clinical SAHS severity reference. The perfor-
mance of the computer screening method is evaluated using
this gold standard.
In this respect, column 6 describes the reference test,
which can either be a retrospective clinical diagnosis or
an overnight recording test, in which case, the type of test
performed (AASM level) as well as whether the test was
performed in the same night or in a different night (as with
respect to the recording analyzed by the computer method)
is indicated. Column 7, on the other hand, specifies the event
definition followed by the gold standard. Indeed when AHI is
used as the quantitative severity reference (most of the cases),
it is reasonable to think that such index would be influenced
by the specific scoring rules and event definitions followed in
each study. Specifically, while from the beginning there has
been a reasonable agreement on the definition of apnea, this
has not been the case for the scoring of hypopneas [5, 41].
Column 7 therefore contains (when present in the study) a
reference to the definition followed for the scoring of these
events. Due to space restrictions, though, for full details on
the event definition (e.g., for apnea scoring or information
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on the sensors), the reader is still committed to checking the
full text within the specific study.
As stated in the beginning of this section, screening
approaches seek the classification of the subject into patient or
normal based on the calculation of a subrogated (computer-
based) severity measure. Performance validation of these
approaches is therefore mostly accomplished by comparing
this classification to the equivalent that results from the use
of the (manually scored) clinical indices. When this clinical
classification is done on the basis of the AHI, the use of a cut-
off in thus needed. This cut-off value is indicated in column
8. The associated validation performance measures of the
computer method as the results of this dichotomous decision
are given in columns 9 to 11. Recall, as stated in Section 3,
that these values correspond to the best operation point
regarding patient classification (SAHS or normal). Finally,
the last column in Table 2 identifies the validation method.
Interpretation of the values in column 12 is as follows: “S”
stands for “Singleton” which means validation results are
obtained from a single dataset of patients (see corresponding
references for more details on how this dataset is arranged in
each case). “TR/TS” stands for “Training/Testing” and applies
to the cases in which the methods have been developed and
parameterized using a training set, whereas validation results
have been obtained using an independent testing set. It may
be the case also where several independent testing sets are
used, and in that case this is indicated as “TS1,” “TS2,” and
so on. In addition, where necessary, the actual number of
patients involved in each of the different sets is indicated in
parenthesis. Finally, “CV” means that validation results have
been obtained by using a cross-validation process. In those
cases, where it applies, also in parenthesis the number of folds
used or else “leave-one-out” is indicated.
Analysis of the related bibliography in this context has
revealed that computer analysis of the oxygen saturation
has been widely used as screening method because of its
simplicity and its lower associated cost with respect to the
full PSG. In this regard, the most widely used approaches
up to the beginnings of the year 2000 relied mostly on the
application of different cut-offs over the computed number
of oxygen saturation dips (oxygen desaturation) per hour
of time, that is, the so-called Oxygen Desaturation Index
(ODI). Many other applications could be found also based
on the cumulative time spent below certain saturation value
(e.g., 90%) [16]. Validity of these methods, however, varies
upon the study sample and the selected thresholds. Actually
a problem with these approaches has to do with the absence
of a consensus to establish the appropriate thresholds.
Bearing that in mind, the work of Daniels et al. [17]
describes the system CADOSA which combines analysis of
the overnight oximetry with evidence from patients history,
a physical examination, and a questionnaire based on the ESS
to assess sleep propensity. Fuzzy set theory has been used
here, precisely, to account for variability in the definitions and
subjectivity of the interpretations. In this work, knowledge
representation and description of the inference process is
illustrated to represent patients’ symptoms and to infer a dif-
ferential diagnosis with particular emphasis on the detection
ofOSA,Central SleepApnea (CSA), periodic limbmovement
syndrome, and upper airway resistance [17].
Alternative characterization of SaO
2
has been tried by
several authors by computing an index of signal variability,
the delta-index [18–20]. Classical spectral analysis based on
Fourier transform has been used to extract relevant features
for patient classification based on the power spectrum.
Examples of these approaches can be found in the works of
Zamarro´n et al. [21, 22], later on byHua andYu [23], andmore
recently in Morillo et al. [24]. Among these approximations,
in general the method relies on the computation of the
Power Spectral Density (PSD) within a specific frequency
subband of interest, followed by the application of linear
regression analysis to determine the best threshold and assess
the predicting performance of the resulting feature.
Based on nonlinear characterization of the saturation
signal, it is worthmentioning a first work of A´lvarez et al. [25]
in which two nonlinear methods, central tendency measure
(CTM) and Lempel-Ziv complexity (LZ), are applied to char-
acterize the SaO
2
recordings. These features are compared
against classical desaturation indices, time spent below a
saturation of 90%, and delta-index.
Later on, Hornero et al. [27] studied the utility of approxi-
mate entropy (ApEn) over the oxygen saturation signal for the
diagnosis of SAHS. The study concluded that patients with
OSA showed a significant increase in theApEnvalues. Similar
conclusions were raised by the same authors in another study
[28]. In a different work, A´lvarez et al. [26] carried out
comparison of classical oximetric indices, regularity indices
from ApEn analysis, and variability indices from CTM anal-
ysis. While results showed that nonlinear methods obtained
better accuracy than classical methods, both ApEn and CTM
analyses showed very similar discriminative capabilities.
Following the previous hypotheses, subsequent works
investigated the use of different machine learning classi-
fiers to help in the classification. Concretely in Victor-
Marcos et al. classifiers based on quadratic (QDA) and
linear (LDA) discriminants, 𝑘-Nearest Neighbor (k-NN) and
logistic regression were tried with different combinations of
features including spectral and nonlinear features (ApEn,
CTM, and LZ). In this study, the classifier based on LDA
with spectral features provided the best performance [29]. In
a later study, the authors added a preprocessing step using
PCA, improving the previous results of their algorithm [30].
Another relevant work in this context is the one by A´lvarez
et al. in which a total of 16 features are included in the study
and selected by means of a step-forward logistic regression
process.The set of features included statistics from both time
and frequency domains, conventional spectral characteristics
from the power density function, and nonlinear features.
Second- and fourth-order statistical moments in the time
domain, the relative power in the 0.014–0.033Hz frequency
band, and LZ were automatically selected as the best features
[34]. In a recent work, the same authors further investigated
the use of genetic algorithms over the same set of features
and using a greater sample of subjects. Using a logistic
regression classifier, the feature selection process returned as
the minimum optimum feature set the one composed of the
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following six features: first, third, and fourth time statistical
moments,median frequency of the spectrum, park amplitude
within the 0.014–0.033Hz, and CTM [35].
Approximations based on the use of ANNs can be found,
for instance, in the work of El-Solh et al. [36]. In this work,
the authors trained a probabilistic neural network fed with a
combination of features to classify patients in either Cheyne-
Stokes respiration, OSA, or no sleep disorder. Inputs to
the neural network included salient features of frequency
analysis, Shannon’s entropy, desaturation indices at 2%, 3%,
and 4%, and the delta-index. In their experiments, the authors
obtained remarkable performance with almost perfect classi-
fication of the 213 subjects included in the study [36].The use
of ANNs can also be found in the works of Victor-Marcos
et al. [31, 32], in which Multilayer Perceptron (MLP) and
Radial Basis Functions (RBF) are used in order to classify the
patients as OSAHS or non-OSAHS using nonlinear analysis
of the oxygen saturation signal, both obtaining similar results.
More recently, and from a regression perspective, Victor-
Marcos et al. used a MLP and a linear regression model in
order to predict the corresponding AHI for each subject from
a set of 14 SaO
2
features. The MLP model generally achieved
higher accuracy in the tested sample. Using different severity
thresholds for binary classification, the model improved its
performance as the AHI cut-off increases [33].
The previous screening approximations used the oxygen
saturation signal as its main source to extract the rele-
vant information. However, besides oxygen saturation, many
approaches based on single signal monitoring are used with
a similar philosophy for SAHS prediction purposes. In this
respect, techniques based on analysis of single-channel air-
flow recordings constitute another widely extended approxi-
mation.
Two recent studies in this respect can be found in works
by Gutierrez-Tobal et al. [37, 38]. In the first one, spectral
analysis of the airflow recordings is performed and spectral
features in the 0.024–0.056Hz band are combined into a
linear regression model. Discriminative capability (patient,
control) of themodel varied depending on the AHI threshold
(5–30) [37]. In the second work, Respiratory Rate Variability
(RRV) is measured throughout the signal and spectral and
nonlinear features (LZ, ApEn, and CTM) are extracted using
both raw and RRV airflow signal. Forward stepwise logistic
regression is then used for feature selection and subjects’
classification. The highest accuracy was obtained for the
model using features extracted from the combination of the
raw airflow and RRV signals with 3 out of the 42 features.
Only spectral features were included within this set [38].
In the same line of a minimal monitoring requirement,
Caseiro et al. [39] propose the application of the Hilbert-
Huang decomposition over 5 minutes of oronasal airway
pressure signal recorded while the patient is still awake.
A similar approach is followed in Salisbury and Sun [40],
though using a different index measure as in the approach of
Caseiro et al.
4.2. Detection of Apneic Events. This category includes those
approximations that seek the individual localization of the
apneic event in the recording. Thus, whereas estimative
approaches described throughout the previous section are
oriented toward obtaining a supplementary measure assess-
ing the necessity of the patient to undergo nocturnal PSG,
the ones included here rather focus on the direct localization,
measurement, and classification of the actual apneic events
throughout the recording.An evaluation of the SAHS severity
can then be calculated directly by counting the number of
events detected and dividing the result by the total sleep time
(AHI) or by the processed recording time (RDI) [42].
A summary table of the different event detection
approaches analyzed throughout this section is shown in
Table 3. Validation results of the different methods are avail-
able inTable 4. Table 4 follows a similar structure as described
before for screening approaches in Table 2. Thus columns 2
to 5 in Table 4 include study population details, respectively,
the database identification, the number and gender of the
participants, the age of the population, and the reference
severity index. Gold standard for the scoring of the events
is again referenced through columns 6 and 7. Similarly to
Table 2, for which variability on the hypopnea definition
would directly influence the scoring of these events, column
6 in Table 4 contains (when present in the study) a refer-
ence to the used hypopnea definition. On the other hand,
because evaluation of the detection approach focuses on
the capacity to perform individual event localization rather
than to perform patient classification, specification of an
AHI threshold is no longer needed. Instead column 8 shows
the number of events over which detection algorithm is
evaluated which have been detected according to the gold
standard. Column 9, in addition, states (when possible) the
detection precision of the algorithm. In column 9, a “C”
means detection is performed in continuum (i.e., limited only
by the precision of the signals’ sampling rate), and otherwise
the number of seconds (step size) that the algorithm uses for
each evaluation is shown. Sometimes the algorithm can score
events in continuum but validation results are provided using
discrete epochs of varying size.These cases are specified using
“val” in the corresponding cells of column 9. Sensitivity and
specificity and further evaluation measures corresponding
to the best operation point of the automatic analysis are
provided, respectively, in columns 10, 11, and 12. The last
column in Table 4 describes, as in Table 2, the validation
procedure. In this case the numbers in parenthesis specify the
number of events used for the validation. On the other hand,
a “P” in this column stands for “Patient,” meaning that the
number of events used in the validation is not specified but
the number of patients/recordings instead is.
4.2.1. Analysis of Pulse Oximetry Recordings. Theutility of the
computerized analysis of the oxygen saturation as screening
method for the diagnosis of SAHS has been already men-
tioned in Section 4.1. Indeed, within the detection setting,
a simple strategy to detect and quantify the duration of
the apneic event can be very well performed based on the
detection of desaturation and/or resaturation patterns in the
oxygen saturation signal. The fundamental hypothesis is that
the reduction in the respiratory flow caused by each apneic
event induces a drop in the arterial blood oxygen concen-
tration levels. Similarly, for resaturation, the assumption is
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Table 3: Summary of apneic event detection approaches.
Category Source Method References
Pulse oximetry
SaO2
Counting on the number of
desaturation and/or resaturation
events
Netzer et al. [16], Flemons
et al. [42]
Online processing + Bagging
classifier Burgos et al. [43]
PPG DAP detector based on PPG Gil et al. [44]
Single-channel
respiratory activity
Abdominal breathing signal Expert system Macey et al. [45]
NAF
Amplitude based thresholding Reisch et al. [46], Pe´pin etal. [47]
ANN Va´rady et al. [48]
Mean magnitude of the second
derivative Han et al. [49]
Flow-power dips, amplitude
based detection, and ODI Nakano et al. [50]
Fuzzy Inference System
Shin et al. [51], Nazeran et
al. [52], Morsy and
Al-Ashmouny [53], and
Al-Ashmouny et al. [54]
Thoracic breathing signal Amplitude based thresholding Reisch et al. [46]
Esophageal pressure Amplitude based thresholding Reisch et al. [46]
FOT Amplitude based thresholding Reisch et al. [46]
Multichannel
respiratory activity
SaO2 + RIP Amplitude based analysis Taha et al. [55]
Airflow + SaO2 TDNN Tian and Liu [56]
NAF + PPG Pulse wave amplitude analysis Sommermeyer et al. [57]
Nasal pressure + FOT Amplitude based featureextraction + thresholding Steltner et al. [58]
Thoracic and abdominal respiratory
signals
Piecewise liner approximation +
time-domain phase difference
detection
Va´rady et al. [59]
NAF + thoracic and abdominal
breathing
Breath-to-breath amplitude
analysis Houdt et al. [60]
Thoracic and abdominal respiratory
effort + ECG + SaO2
SVM Al-Angari and Sahakian[61]
EEG + ECG + nasal pressure +
oronasal temperature + right EOG +
EMG
Wavelets + LAMSTAR ANN Waxman et al. [62, 63]
Airflow + SaO2 + thoracic and
abdominal breathing Fuzzy Inference System
A´lvarez-Este´vez and
Moret-Bonillo [64], Maali
and Al-Jumaily [65], and
Otero et al. [66, 67]
that, after the apneic event causing a respiratory insufficiency,
an episode of compensatory hyperventilation must follow,
inducing a fast increase in the oxygen saturation levels.
A recent approximation using the oxygen saturation
as the source signal is described in the work of Burgos
et al. [43] in which detection of the apneic event can be
performed in real time.This contrasts most of the approaches
in which analysis is usually carried out once the recording has
finished (offline). Burgos et al. propose a feature extraction
process performed on minute-by-minute time step followed
by a classification stage. Several classifiers are tested on the
extracted features, the bestmethod beingmetaclassifier boot-
strap aggregating (Bagging) based on alternating decision
trees (ADTree). Besides, in this work, the resulting method is
afterwards implemented into amobile PDAdevice connected
via GPRS to the hospital allowing the physician to perform
remote patient follow-up [43].
Pulse photoplethysmography (PPG) signal has been
proposed as an alternative to traditional arterial oxygen
saturation that reflects vasoconstriction changes. In the study
of Gil et al., validity of this signal is assessed, and an automatic
detector of apneic events based on PPG (DAP detector) is
developed and compared to detection methods based on
amplitude changes in the airflow and in the oxygen saturation
[44].
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4.2.2. Analysis of Single-Channel Respiratory Activity. Besides
oxygen saturation, detection approximations based on single-
channel analysis can be found elsewhere. Using the abdom-
inal breathing signal as reference and focusing on the detec-
tion of central events in infants, the work of Macey et al. [45]
can be mentioned. In this work, an expert system is designed
which relied on the use of ANNs to perform the detection
task.
Amplitude based thresholding of different respiratory
derivations for online detection of the apneic events is
discussed in the work of Reisch et al., including nasal airflow
(NAF), thoracic excursion, Pes, and Forced Oscillation Tech-
nique (FOT) [46]. Va´rady et al. also proposed an algorithm
for the online detection of apnea and hypopnea events,
while their method is based on the analysis of NAF and/or
Respiratory Inductance Plethysmography (RIP) derivations.
Instantaneous respiration amplitude and interval signals were
derived from the respiratory signals and several feedfor-
ward neural architectures were investigated. Best reported
performance was obtained for the model when using only
information from the processing of the NAF derivation [48].
The work of Han et al. describes the development of a
detection algorithm based on the mean magnitude of the
second derivative of NAF using a thermocouple. According
to the authors’ results, the proposed algorithm reached better
performance as compared with a traditional algorithm based
on amplitude analysis [49]. Later on, in Pe´pin et al. [47],
the authors dedicated one channel of an ECG Holter to
the recording of nasal pressure and developed an automatic
algorithm to search for apneic events in this signal.
The proposal of Nakano et al. is based on the spectral
analysis of different airflow derivations [50]. The developed
algorithm, based on detection of flow-power dips, was firstly
developed using a set of patients in which airflow was mea-
sured with a thermal sensor. The resulting method was then
evaluated against a conventional time amplitude detection-
based algorithm and the detection of oxygen saturation falls
(ODI). A second group of patients in which airflow was
recorded through nasal-prong pressure transducer and a
thermocouple was used to assess generalization capabilities
of the algorithm over alternative derivations. Event-by-event
validation against visually scored events showed similar
behavior for the thermal and for the thermocouple channels;
however sensitivity when using these derivations was lower
when compared with the nasal pressure sensor. These results
agree with the known difference in sensitivity among the
tested sensors [73, 74]. In contrast, the algorithm showed
stability when using different optimum thresholds across the
different channels. With regard to the comparison with other
methods, in terms of AUC, the developed algorithm showed
better results with respect to other amplitude based analyses
of airflow and similar values to the analysis based on ODI
[50].
Modeling the diagnostic process but from a particular
knowledge engineering perspective is the object of another
specific group of methods. Certainly, achieving an inter-
pretable model of intelligent human behavior is the purpose
of knowledge-based symbolic approaches.Within this group,
the so-called rule-based systems have been widely used
for diagnostic tasks in which medical knowledge is coded
in form of heuristic rules. Inference in these systems is
performed by a process of chaining through rules recursively
in which activation depends on the particular case presented
at the input [75]. Specifically fuzzy inference systems have
demonstrated to be specially suited tomodel human behavior
in domains where data and interpretation processes have a
component of imprecision. Medical diagnosis, and SAHS in
particular, is a good example of such domains [76].
Following this line, online detection of apneic events is
performed using a rule-based system in the work of Shin et
al. [51]. The objective is to develop a feedback variable to be
used for automated control of CPAP therapy. For that purpose
a fuzzy inference system (FIS) is developed using three input
variables, and analysis is carried out on a breath-by-breath
basis from respiratory airflow measurements: concretely, (1)
the relative duration of inspiratory flow limitation in each
breath, (2) the degree of hypopnea relative to the past 15
breaths, and (3) the intensity of airflow-derived snoring.
This approach contrasts with conventional auto-PAP devices
which usually rely on rigid rules based on thresholds over
the feedback variable. It allows, in addition, a much greater
degree of smoothing in the decision-making process.
Nazeran et al. [52] have developed also a FIS which
operates over the airflow variable. The system is designed
to differentiate between apnea and hypopnea events, and it
used parameters of normalized area and standard deviation.
Later on, the works of Morsy and Al-Ashmouny [53] and Al-
Ashmouny et al. [54] modeled a sleep apnea detection system
using three membership functions to differentiate three
regions over the input space of the nasal airflow variable. The
authors proposed a two-step approach to classify respiratory
events either as abnormal or normal breathing.
4.2.3. Analysis of Multichannel Respiratory Activity. The clas-
sical approach for the detection of apneic events in the
respiratory signals follows a multichannel approach, and,
according to the standards, it involves the analysis of at least
one derivation from each of the following signals: airflow,
oxygen saturation, and thoracoabdominal respiratory move-
ments [6].
Following this approach, the work of Taha et al. can be
firstly mentioned [55]. In this work, the analysis starts with
the detection of desaturation events in the oxyhemoglobin
saturation signal, and then the sum of RIP is analyzed to
detect periods of no breathing.The resulting detected periods
are subsequently classified as apneas or hypopneas according
to the corresponding baseline breathing reduction. Apneas
were further classified into central, mixed, or obstructive
based on the presence of abdominal or rib cage breathing
efforts [55].
The idea of combining oxygen saturation with other
respiration signals has been used in subsequent works. For
example, to use the ability of time delayed neural networks
(TDNN) to deal with prediction and classification tasks in
contexts involving the temporal variable was the main idea
of the work of Tian and Liu [56]. In this work, features from
the airflow and from the oxygen saturation signals are fed to a
TDNN on a second-by-second basis to classify the signal into
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periods of normal respiration, apnea, or hypopnea. Another
example is the work of Sommermeyer et al. [57], in which
an oximeter-based PPG signal is used in combination with
a nasal cannula for the detection and also differentiation
of central and obstructive apneas. For that purpose, pulse
wave amplitude (PWA) and pulse rate are calculated from
the oximeter recording, and template functions are used for
pattern recognition. Respiration effort is derived by analyzing
fluctuations of the PWA signal which allow the estimation of
an effort ratio.
Steltner et al. developed diagnostic software for the offline
detection and classification of respiratory events by analyzing
the time series of the nasal mask pressure derivation and
FOT, signal as alternatives to the common thoracoabdominal
strain gauges and RIP. The method is based on confronting
amplitude features from these signals with the appropri-
ate analytically derived thresholds. The algorithm provided
results comparable to those of visual analysis by human
experts (weighted Kappa statistic) though mean absolute
values of agreement were somewhat low (below 0.5) [58].
Almost contemporary, Va´rady et al. proposed an online
analysis approach for both detection and classification of
apneic events based on the phase difference between the
thoracic and the abdominal respiration [59].
More recently, Houdt et al. [60] published a work in
which an algorithmwas developed based on breath-to-breath
analysis of the respiratory recordings (nasal airway pressure
and thoracic and abdominal movements). For that purpose,
respiratory signals were divided into half waves using period
amplitude analysis and characterized in terms of duration,
amplitude, and slope. Apneic events were then detected by
dynamical computation of the normal respiratory values and
comparing the corresponding respiratory values for each
cycle. Further classification of the events into obstructive,
central, and mixed was also carried out based on amplitude
analysis of the thoracic and abdominal movements [60].
The goal of the study of Al-Angari and Sahakian was to
evaluate the classification of whole-night normal and apneic
epochs using extracted features from the phase and magni-
tude of the respiratory effort signals (thoracic and abdomi-
nal), compared and combined with some other features from
ECG and oxygen saturation signals. SVM classifiers with
linear and polynomial kernels were used. The results of their
experiment showed that the best performance was achieved
when features of the three signals are used [61].
Alternatively, in the work of Waxman et al., the major
objective was to focus on the prediction task. For that
purpose, their method was tested using different prediction
delays and segment durations (30–120 seconds). Several PSG
channels were used of which features were extracted using
wavelet processing. In their work, the authors proposed the
use of a special kind of artificial neural network, namely,
LAMSTAR, especially suited to deal with large amounts of
data and to provide meaningful relationships to the net-
work’s inputs. As expected, prediction performance resulted
inversely proportional to the prediction delay. The authors
tested also detection on the basis of 30-second segments.
For this task they found that while oronasal temperature was
the most meaningful signal for the detection of apneas, for
hypopnea detection, the most important signal was nasal
pressure [62, 63].
Intelligent-based modeling of the respiratory signals (air-
flow, oxygen saturation, and thoracoabdominal movements)
in a multichannel setting has been proposed in the work
of A´lvarez-Este´vez and Moret-Bonillo [64]. In this work
signal processing methods are firstly used to extract features
over each channel. By using temporal constraint rules, the
individual features are then grouped together in form of
reasoning units. The resulting reasoning units are finally
evaluated by means of a FIS to characterize them as either
apnea, hypopnea, or normal breathing with different degrees
of membership [64].
The use of fuzzy inference techniques for the detection of
apneic events can also be found in other works. For example,
based on the previous work of A´lvarez-Este´vez and Moret-
Bonillo [64], Maali and Al-Jumaily have proposed the use of
genetic algorithms as a mechanism to generate fuzzy rules
directly from data [65]. In a recent work by Otero et al., fuzzy
detection methods are also used for marking apneic intervals
in the respiratory signals. This method facilitates knowledge
acquisition by using an interface to model the membership
functions, thus allowing additional system parameterization
[66]. In a posterior work, Otero et al. extended themethod by
incorporating a structural model that permits the projection
of a patient’s physiological parameters into a computable
representation. The purpose of such a representation is to
allow the discovery and follow-up of the temporal evolution
of different signal patterns of interest [67].
4.3. Classification of the Apneic Event Type. Theprincipal goal
of the classification task is to characterize the detected apneic
event according to the nature of its origin—obstructive,
central, or mixed. The main purpose of the works referenced
under this is to accomplish such a task.
A summary of the analyzed methods regarding apneic
event classification can be found in Table 5. In this table,
the third column refers to the possible classes that result
as the output of the algorithm. Subsequent Table 6 reports
validation results of the different methods. Interpretation
of data in this table is similar to that of Table 4 for the
detection methods. The fundamental difference lays here in
the fact that the classification task does not account for the
time localization of the apneic event, but it assumes that
the apneic occurrence has been already detected, and the
objective is then to classify this occurrence according to
its type. Therefore, in Table 6, it does not make sense to
specify the classifiable unit in a separate column. And, for the
same reason, explicit reference to the definition used for the
detection of hypopnea events is no longer relevant. Instead
column 7 in Table 6 provides information on the criteria used
for the classification of the event type. For the rest, structure
of Table 6 is analogous to Table 4.
Among analyzed approximations, several have been
already mentioned in the preceding section for which they
also included the classification step as part of the algorithm.
This is the case of the works of Reisch et al. [46], Taha et al.
[55], Sommermeyer et al. [57], Steltner et al. [58], Va´rady et
al. [59], and Houdt et al. [60]. The work of Al-Ashmouny
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Table 5: Summary of apneic event classification methods. S = snoring; H = hypopnea; N = normal breathing; OH = obstructive hypopnea;
CH = central hypopnea; CA = central apnea; OA = obstructive apnea; MA = mixed apnea; N/A = not available.
Source Method Classes References
NAF, thoracic breathing signal,
esophageal pressure, and FOT Amplitude based thresholding
H1, H2, OA, CA, and
MA Reisch et al. [46]
Airflow + thoracic and abdominal
effort signals
Fuzzy Inference System N, H, CA, and OA Al-Ashmouny et al.[54]
Self-advising SVM CA, OA, and MA Maali et al. [77]
SaO2 + RIP Amplitude based analysis
N, H, OA, CA, and
MA Taha et al. [55]
PPG + NAF Pulse wave amplitude analysis OA, CA Sommermeyer et al.[57]
Nasal pressure + FOT signal Amplitude based feature extraction +thresholding
N, H, OA, CA, and
MA Steltner et al. [58]
Thoracic and abdominal respiratory
signals
Piecewise linear approximation +
time-domain phase difference detection N, OA, and CA Va´rady et al. [59]
Multiresolution DWT + ANN CA, OA, and MA Sezgin and EminTagluk [78]
NAF + thoracic and abdominal
breathing Breath-to-breath amplitude analysis
N, H, OA, CA, MA,
and N/A Houdt et al. [60]
NAF + Pes + Pgas signals Hidden Markov models N, S, CA, and OA Al-Ani et al. [79]
Airflow + thoracic effort signals Amplitude analysis + wavelets + BayesianANN N, CA, OA, and MA
Fontenla-Romero et
al. [80]
Abdominal effort signal Multiresolution DWT + ANN CA, OA, and MA Tagluk et al. [81, 82]
Thoracic effort signal Discrete wavelet decomposition + SVM RFEfeature selection + combination of ANNs CA, OA, and MA
Guijarro-Berdin˜as et
al. [83]
NAF, Pes
Amplitude based features + Adaboost
classifier (Pes); inspiratory flow limitation
detector + feature extraction + diagonal
quadratic discriminant (NAF)
OH, CH Morgenstern et al.[84]
et al. [54] has been previously mentioned as well which
extends the single-channel approach described in Morsy and
Al-Ashmouny [53] by adding a classification stage using the
information extracted from the thoracic and the abdominal
excursions.
Besides them, others can be found that center specifically
in the classification step. Al-Ani et al. [79], for example, pub-
lished a method to perform sleep apnea classification using
HiddenMarkovModels applied to simultaneous recording of
NAF, Pes, and Gastric Pressure (Pgas).
Later on, Fontenla-Romero et al. [80] developed a system
in which the detection of apneic events is performed from
the airflow signal, and, once detected, a wavelet processing
is applied to the corresponding intervals of thoracic effort
signal. A Bayesian ANN is finally in charge of classifying the
interval as central, obstructive, ormixed.Theworks of Tagluk
et al. [81, 82] and Sezgin and Emin Tagluk [78] are also based
on the use of wavelets for feature extraction and subsequent
classification by means of a neural network. In these works,
the airflow signal is examined togetherwith the analysis of the
thoracicoabdominal respiration. In this respect, the authors
concluded that when features from the thoracic channel are
used, better performance can be obtained in the classification.
More recently, Guijarro-Berdin˜as et al. have presented
a method that combines machine learning techniques and
expert knowledge that improves the results of the previous
approaches [83]. Maali et al., on their part, have recently
proposed a machine learning approach adapting the classical
SVMs, resulting in the so-called self-advising SVM technique
and applying it to the apnea classification problem [77].
Specifically focused on the classification of hypopneas, in
the study ofMorgenstern et al. [84], two differentmethods are
presented in order to differentiate between obstructive and
central hypopneas.The first technique is proposed using a Pes
sensor (an invasive method) in which features are extracted
and used to train different machine learning classifiers
based on discriminant analysis, SVMs, and Adaboost. The
second method was implemented to assess the validity of
a noninvasive approach using an airflow tracing recorded
with nasal cannula. Similarly, several features were extracted
and a diagonal quadratic discriminant was fed with four
features. Accuracy of the classification was found lower with
the second noninvasive approach [84].
4.4. Comprehensive Diagnostic Systems. The term compre-
hensive diagnostic systems is here applied to refer to those
systems that comprise—as a minimum—the classification
of sleep stages and the analysis of the respiratory activity.
This characteristic differentiates comprehensive diagnostic
systems from the previous approaches which, in general, are
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Table 7: Summary of comprehensive diagnostic systems.
System Method References
PSG-EXPERT Processing of symbolic information + certainty factors Fred et al. [85]
— Data fusion of complex symbolic objects Ugon et al. [86]
TASAS Reasoning with symbolic objects using causal constraint temporalnetworks + handling of uncertainty
Ferna´ndez-Leal et al.
[87, 88]
— Automatic pattern discovery and rule generation on multichannel timeseries Guimaraes et al. [89]
SAMOA Signal processing + symbolic rule-based reasoning and intelligentdiagnosis
Cabrero-Canosa et al.
[90, 91]
MIASOFT
Signal processing + intelligent analysis of sleep macro- and
microstructure and respiratory activity and diagnosis + reasoning
mechanisms to support uncertainty in the decision process
Alvarez-Estevez et al.
[92–96]
rather specialized in the accomplishment of specific subtasks,
such as patient screening, analysis of the respiratory activity,
or classification of the apneic event type. In contrast, the
approaches referenced in this section involve analysis of the
PSG signals in the context of a comprehensive sleep analysis,
and thus the name. Ultimately, these approaches are aimed at
constituting global solutions in the form of clinical decision
supporting systems in the context of SAHS.
Table 7 summarizes the works falling under this category
and the corresponding validation results are described in
Table 8. In the case of comprehensive approaches, the object
of the validation may vary depending on the focus of the
corresponding reference. Thus, in columns 9, 10, and 11 of
Table 8, the word “Events” is indicated when the results refer
to detection of apneic events, and otherwise the specific
type of the event is indicated in parentheses. On the other
hand, when validation data is provided with regard to the
capabilities of the method to classify individuals as SAHS
patients or normals based on the calculation of the AHI,
the code “Diagnosis/X” is specified in which X stands for
the AHI cut-off value used for such purpose. Note that
this classification is similar to that performed in Section 4.1
when screening approaches were analyzed. The fundamental
difference is, of course, the analysis approach. Screening
approaches seek the maximum possible simplification of the
test, the main objective is to hold a screening function for
triage, and, as a consequence, when estimation of the AHI
is performed, this is usually done over a simplified subset
of the signals contained in the PSG. Analysis in the case
of comprehensive systems, in contrast, tries to reproduce
as much as possible the full standard analysis of the PSG.
In other words, the expected results of a comprehensive
system ideally should match the outcome of a full analysis
performed by an expert human scorer. Recall nonetheless
that, formally speaking, SAHS diagnosis cannot be based
exclusively on AHI, but especially when the severity index is
low, SAHS diagnosis may require the presence of additional
symptomatology [9].
Within this group, wemay start bymentioning the system
PSG-EXPERT [85], which is presented as the particular-
ization for the case of SAHS of a more general integrated
environment for the development of diagnostic expert sys-
tems. PSG data are extracted by using signal processing
and are inserted into a database organized according to the
following categories: clinical history, hypnogram data, sleep
parameters, spectral data, EEG time related activity, and
non-EEG activity. The system then carries out the diagnosis
through a reasoning mechanism over the extracted data
which supports the handling of imprecise information using
a model of certainty factors [97]. It also includes a validation
module which allows testing of concrete patient’s cases by
comparing the results of the analysis with those of themedical
experts. Perhaps themain limitation of the system is due to its
general purpose philosophy, for which it just operates at the
symbolic level. In other words, processing and segmentation
of the raw signal have to be performed separately and the
resulting data must be afterwards inserted into the database.
In spite of its built-in validationmodule, no validation results
have been reported assessing the actual performance of the
system [85].
Following with the symbolic perspective, Ugon et al. [86]
present an approach that relies on the fusion of complex
symbolic objects connected to each other following a set
of simple predefined rules. The approach of Ugon et al.
incorporates a module that handles sleep scoring following a
signal processing approach, which extracts features from the
neurophysiological signals, and uses binary decision trees to
end up with the final labeling of the sleep epochs. Graphical
but not numerical validation results of this system can be
found in [86].
The system TASAS emerged from the particularization
for SAHS of a more general framework for the design
of expert systems with special emphasis on the handling
of temporal knowledge [87]. Concretely, the system serves
from the use of the Causal Constraint Temporal Networks
(CTCN) representational model which allows handling of
temporal information between symbolic items, modeling
them either as points or as intervals, and implementing
effective mechanisms to manage causality [98]. Under the
modeling framework provided by TASAS, expert knowledge
can be implemented describing temporal patterns that are
used to detect physiological evidences of apneic events in the
PSG. Validation details of the TASAS system can be found in
[87]. A recent extension of this model to support uncertainty
in the reasoning process bymeans of the fuzzy logic paradigm
can be found in Ferna´ndez-Leal et al. [88].
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Two important considerations have to be taken into
account at this point. First, while the three previous systems
carry out the diagnosis from a knowledge-based perspective,
these systems actually lack built-in procedures for the analysis
of the raw signals. They instead operate at the symbolic level.
Second, modeling of the causal and temporal relationships
between the different events requires the so-called knowledge
acquisition stage to make medical expertise explicit in the
form of temporal and/or production rules. However, this is
a well-known bottleneck in the design of expert systems [99].
The approximation of Guimaraes et al. tries to face the
previous shortages and presents a method for the discovery
of temporal patterns in multivariate time series and their
subsequent conversion into a linguistic knowledge represen-
tation. The method is specifically applied to the context of
SAHS diagnosis [89]. The idea relies on the use of several
levels of abstraction on a bottom-up analysis schema. In
this respect, self-organizing neural networks are used to
discover elementary patterns in the time series, and machine
learning algorithms are subsequently used to process the
patterns generating a rule-based description. At the next
levels, temporal grammatical rules are inferred. Although the
work of Guimaraes et al. cannot be regarded as a complete
comprehensive approach, for which it only involves the set of
respiratory signals, it does constitute an interesting integra-
tive framework by the linking of several artificial intelligence
methods and face the problem of knowledge acquisition
on multichannel PSG time series. Further evaluation of
the method has to be performed though, as the authors
themselves suggest, in order to assess its actual clinical
relevance on the context of SAHS diagnosis [89].
The system SAMOA is one of the first approaches to
integrate both artificial intelligence and classical signal anal-
ysis techniques for the development of an integrated product
which, in addition, is able to provide explanation of its results
[90, 91]. Architecture of the SAMOA system is mainly inte-
grated by four different modules: (i) the polysomnographic
prescription module, (ii) the module for the characterization
of the respiratory activity, (iii) the module for the construc-
tion of the hypnogram, and (iv) the diagnostic module.
While the system SAMOA solvesmany of the problems of
its predecessors, still a common drawback on these systems is
the use of fixed protocols and thresholds while automatically
analyzing the raw signals from the PSG. For example, the
use of fixed thresholds to identify amplitude changes in the
respiratory cycles may cause incorrect assessment of the
baseline breathing. On the other hand, still in SAMOA,
besides counting with mechanisms for generation of the
hypnogram, analysis of the raw EEG for the detection of the
different rhythms and transitory components is carried out
by using a supplementary system [100].
In an endeavor to solve the previous drawbacks, the
MIASOFT system has been recently developed [92].This sys-
tem contributes to supporting its analysis capabilities under
two fundamental pillars: (i) its comprehensive approach,
in which neurophysiological activity is used as a context
for the interpretation of the detected respiratory events,
and (ii) the implementation of mechanisms to handle data
imprecision which mimic human’s reasoning procedures
under the principles of generalization and approximation
[92]. There are two well differentiated groups of modules
in the MIASOFT system: (i) those specialized in the anal-
ysis of the respiratory activity and (ii) those specialized in
the processing of neurophysiological activity. Respiratory
analysis is structured into three submodules for the iden-
tification of apneic intervals, characterization of the SaO
2
signal, and the analysis of the respiratory effort [93]. On
the other hand, neurophysiological analysis is organized into
seven submodules: three are responsible for cerebral activity
characterization, eye movements’ detection, and muscle tone
analysis. This neurophysiological information is fed to a
module in charge of obtaining patient’s hypnogram [94].
MIASOFT system, besides, is provided with mechanisms for
the analysis of the sleep microstructure and to deal with
the detection of transient events including microarousals
[95, 96], sleep spindles, and K-complexes.The whole analysis
in this system is concurrently assisted by additional modules
providing functionality for artifact detection, temporal infor-
mation correlation, and inference with special emphasis in
the support of uncertainty and imprecision in the decision
process [92].
5. Analysis and Validation of
Commercial Approaches
Even though current automatic SAHS diagnostic systems
still present some shortages, for the clinician, the simple
fact of being able to carry out an offline analysis over a
digitalized recording yet represents an important evolution.
Advantages include not only the amount of saved paper,
but many others such as the possibility to visualize the
signals over different time and amplitude scales, easiness in
the annotation of the detected events, or the possibility of
incorporating supporting tools that automate, at least in part,
the scoring task. Indeed, from a commercial perspective,
there is already some time since the sleep labs were equipped
with computer scoring systems that operate over the fully
digital overnight registrations.
An example is the system Polyman, which strictly
speaking is not commercial software, but it is an EDF(+)-
compatible viewer and sleep scoring supporting program
originally created by Kemp and Roessen [101]. Polyman
includes several aiding tools that can perform automatic anal-
ysis over the common sleep scoring subtasks. The program
allows the user to set up diverse configurations for visual
analysis of the digital recording. Each signal can be freely
filtered, adjusted, and automatically analyzed. Automatic
analysis of frequency content (FFT), threshold crossings,
neuronal feedback analysis [102], and rectified EMG can be
applied to the signals on the screen. It also supports manual
scoring of sleep stages, apneas, leg movements, and arousals
according to standard R&K or AASM rules. The scorings are
kept in standard EDF+ files and a report of standardized sleep
quality parameters can be produced. A licensed version is also
available that includes additional modules for the automatic
scoring of limb movements, respiration, body position, pulse
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rate, ECG, and oxygen saturation. Polyman does also support
synchronization with video files [103].
The trend is indeed during the last years in which new
commercial systems are continuously appearing in the mar-
ket providing new capabilities regarding automatic analysis of
the PSG.The ultimate use and acceptation of these automatic
capabilities in the clinical routine, however, are still under
discussion, for which further and proper validation of these
systems is of fundamental importance. In the following we
shall briefly discuss some of the validation studies that have
appeared during the last years on the research literature
regarding commercial approaches that perform automatic
analysis in the context of SAHS.
Table 9 summarizes the corresponding literature review
on this topic. In Table 9, the second column makes reference
to the device type according to the commonly used classi-
fication proposed in 1994 by the American Sleep Disorders
Association [104]. According to this classification, Type-1
category refers to the standard clinical PSG, considered as
the reference to which the other monitor types are compared.
Type-2 devices incorporate a minimum of seven channels,
including EEG, EMG, and EOG, allowing sleep staging, and
a set of respiratory signals, at least ECG, airflow, respiratory
effort, and oxygen saturation, therefore allowing calculation
of the AHI. Type-3 monitors incorporate a minimum of four
channels with at least two channels of respiratory movement,
or respiratory movement and airflow, and usually heart
rate and oxygen saturation. Direct estimation of the sleep
profile (hypnogram) with Type-3 devices cannot therefore be
performed and only estimative subrogates of the actual AHI
(e.g., RDI) can be obtained to evaluate the SAHS severity.
Finally, Type-4 monitors use at least one respiratory channel,
usually either airflow or oxygen saturation. A monitor that
does not meet the criteria for Type-3 (i.e., a monitor that
measured one to three channels or does not include airflow
despite having four channels) is classified as Type-4 [104].
Columns 3 to 6 in Table 9 include study population
details, respectively, identification of the dataset, number
and gender of the participants, age of the population, and
the reference severity index. Gold standard for validation is
defined in columns 7 and 8. In column 8, explicit reference
to the definition used for the scoring of hypopnea events is
given when available for the corresponding study.The reason
for that is that validation studies of this kind of devices do
usually consider the AHI reported by human expert scorers
as its reference, and as it was the case before for screening
and detection approaches (see Tables 2 and 4), this index
can be partly conditioned by the variability associated with
the definition for the scoring of these events. Column 9
of Table 9, in addition, indicates whether the recordings
analyzed by the computer method were carried out in in-lab
attended conditions (L) orwere performed at home (H). Gold
standard reference AHI cut-off value used for the validation
of the system for patient classification is shown in column
10. The corresponding quantitative validation measures of
sensitivity and specificity are shown in columns 11 and 12,
and additional validation measures such as the area under
ROC curve (AUC), Kappa index (𝜅), intraclass correlation
coefficient (ICC), and Pearson’s linear correlation index (𝑟)
are shown in subsequent column 13. Finally a difference
with previous validation tables in previous sections is that,
in Table 9, the column showing the validation method is
omitted for simplification given that in all references the
method used is “S.”
A first example of validation of Type-1 devices can be
found in the work of Pittman et al. [105] which describes
the validation of the Morpheus I (WideMed Ltd., Israel)
sleep scoring system. This system is aimed at performing a
comprehensive analysis of the PSG recording, thus including
both neurophysiological and respiration data.
Somnolyzer 24× 7 (Philips Respironics,TheNetherlands)
is also comprehensive software that has been integrated into
an e-Health solution platform. It works as a centralized
server so that involved centers can upload their resulting
PSGs, receiving back scorings and the corresponding report.
Description of the system and validation results according
to reliability in automatic sleep scoring capabilities regarding
R&K criteria [135] can be found in Anderer et al. [136].
Posterior adaptation and validation regarding the AASM
criteria [137] have been published in Anderer et al. [138].
Regarding analysis of respiratory signals and SAHSdiagnosis,
Woertz et al. [107] described the use of this system to test
a database of 51 subjects and assess the AHI agreement in
comparison to human scorers.
Validation of the 𝛼-Somnostar 4100 (SensorMedics Cor-
poration, USA) system has been performed in the work of
Barreiro et al. [108].This system records signals of EEG, EOG,
EMG, ECG, digital pulse oximetry, thoracic and abdominal
movements, body position, and oronasal flow. The software
provides functionality for the automatic analysis of the
respiratory function and for the classification of sleep stages
from the EEG. According to the validation of Barreiro et al.,
however, low concordance has been shown between results of
the automatic analysis and those of expert’s manual revision,
especially in the detection of hypopnea events and in the
classification of sleep stages [108].
5.1. Portable Devices. Parallel to the development of in-
lab systems, a growing interest in the last years is toward
the design of portable devices for the outpatient (in-home)
monitoring. In general, literature regarding validation of
portable devices in the diagnosis of SAHS is extensive and
previous reviews in this respect can be found in [104, 139, 140]
andmore recently in [42] and in [141]. Still today, however, the
actual role of portable devices as to substitute full PSG in the
diagnosis of SAHS has to be properly assessed.
Focusing on automatic analysis, Table 9 shows validation
results of some of these commercial portablemonitors. In this
respect, and as it was previously stated, we may specifically
consider as portable the devices under categories Type-2,
Type-3, and Type-4 [104].
Morpheus Hx (WideMed Ltd., Israel) is a bedside com-
puterized analysis system that can be connected to a standard
hospital monitor and utilizes mainly respiration (respiratory
impedance, end-tidal carbon dioxide, and SpO
2
) and ECG,
for the extraction of autonomic nervous system activities
yielding to sleep and wake states, and detects respiratory
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events using the morphology of the respiration and desatu-
ration [109].
Apnea Risk Evaluation System (ARES, Advanced Brain
Monitoring Inc., USA) is a Type-3 device composed of a
hardware part that carries out the signal acquisition, ARES
Unicoder, and software performing analysis of the recorded
information, ARES Insight software [110]. The device records
the following signals by means of a casing attached to the
patient’s head: oxygen saturation, pulse, snore (through a
microphone), and body and head position (using accelerom-
eters). In the validation study of Ayappa et al. [111], the
system is expanded by adding measurement of airflow by
nasal cannula connected to a pressure transducer. From one
recording, ARES Insight software analyzes the signals to
compute an indirect measure of the number of apneic events
per hour of recording (RDI). Calculation of this measure is
based on the analysis of the oxygen saturation signal search-
ing for desaturation and resaturation patterns to obtain an
estimation of the number of apneic events. Incorporation of
airflowmeasure also allows computation of AHI based on the
airflow channel. Measures comprising pulse, snore, and sleep
position serve as contextual information to discard invalid
desaturation and also to detect awakenings that confirm the
presence of the apneic event. These awakenings should not
be confused with EEG arousals since the software does not
provide any analysis capabilities over the neurophysiological
signals. Validation results of this system can be found in the
works of Westbrook et al. [110], Ayappa et al. [111], and To et
al. [112].
Sommocheck (Weinmann GmbH, Germany) is Type-3
device addressing portable monitoring of patients in risk
of SAHOS. It consists of a device attached to the chest of
the patient that records the signals of airflow (thermistor),
snore (microphone), oxygen saturation and pulse (finger
sensor), and body position (using an integrated sensor in the
main unit) [113, 142]. Software provided with the unit allows
the physician visualization and automatic analysis of the
recorded signals.The analysis counts the number of desatura-
tion and apneic events (apneas and hypopneas) and calculates
basic parameters of ODI, Apnea Index (ApI), Hypopnea
Index (HI), and AHI, respectively, as the number of desatu-
ration events, apneas, hypopneas, and apneas/hypopneas per
hour of sleep. In the validation study of Ficker et al. [113],
automatic analysis capabilities of these devices on in-lab PSGs
are tested against experts manual scoring.
Type-4WristOx 3100 (NoninMedical Inc., USA) consists
of two parts: pulse oximeter hardware (Nonin WristOx
3100) and software for the analysis of the recorded SaO
2
signal (nVision 5.0) [114]. SaO
2
signal can be recorded at
several sampling frequencies (1Hz, 0.5Hz, and 0.25Hz). The
analysis algorithm is based on the counting of the number
of desaturation events to estimate the amount of apneic
occurrences per hour of sleep. Validation results for this
device can be found in the work of Nigro et al. [114].
WatchPAT (ItamarMedical Ltd., Israel) is a Type-4 device
worn around the wrist with two finger probes that extend
from the main body of the device; one is an opticopneumatic
sensor that carries on registration of the Peripheral Arterial
Tonometer (PAT) signal and the other measures arterial
oxygen saturation [115]. Heart rate signal is derived from
PAT and the body of the device also contains an actigraph
to estimate sleep time and differentiate it from wake time
[115, 116]. Respiratory events in this device are detected with
an automated algorithm using a combination of PAT signal
attenuation, desaturation on pulse oximetry, and changes in
heart rate [116, 143]. For validation details on this device, the
reader may want to check the works of Ayas et al. [115], Bar et
al. [116], Pittman et al. [117], or Zou et al. [119].
ApneaLink (ResMed, USA) is a Type-4 three-channel
device that measures airflow (nasal pressure transducer),
oximetry, and pulse, providing an AHI estimation based on
recording time. Both automated and hand-scored methods
are available through the ApneaLink software. In the auto-
matic setting, by default an apnea is defined as a decrease in
airflow by 80% of baseline for at least 10 s with maximum
duration of 80 s. Hypopnea, on the other hand, is defined
as a decrease in airflow by 50% of baseline for at least 10 s
and with maximum duration of 100 s [120]. The ApneaLink
does not distinguish between obstructive and central events
because the signal is based only on airflow and there is no
recording of respiratory effort [121]. The sampling rate of the
flow signal is 100Hz, with a flow-sensor effective range of
−10 to 10 cmH
2
O and a 16-bit signal processor. The signal is
processed by linearizing, filtering the noise and zeroing to
baseline. Flowmeasurements are digitalized and downloaded
to a PC [122]. Validation of the device has extensively been
done and in the literature several references can be found in
this respect [120–125].
Somnolter (Nomics, Belgium) type-3 device records
nasal flow, oxygen saturation, body position, thoracic move-
ments, and jaw movements. The automatic analysis of
the traces is based on a multisignal approach to detect
sleep apneas/hypopneas and sleep/wake states [126]. For the
recording of the midsagittal jaw movements, the voltage is
sampled at 10Hz, digitally linearized, and the corresponding
mouth opening is stored with the other PSG channels in
an EDF file [144]. The automatic scoring applied over the
nasal airflow to delineate respiratory events of at least 10
seconds is then based on the following rules: apneas occur
if an airflow reduction of more than 80% appeared within
10 seconds; hypopneas are scored if an airflow reduction of
more than 30% occurred in association with desaturation of
≥4% orwith a salient jawmovement following the respiratory
event, connected with an arousal [126]. A salient jaw move-
ment is characterized by high amplitude or discontinuous
movements in the time signal. The system is also able to
classify apneic events into obstructive, central, and mixed
[145]. With regard to the sleep/wake trace provided by
the automated analysis, wake states are characterized by
“up” body positions or very high or “chaotic” jaw activity
[146]. Validation of automatic scoring performance against
simultaneous visual-scored in-lab PSG recordings has been
carried out in Cheliout-Heraut et al. [126].
Embletta device (Natus Medical Inc., USA) is a Type-3
monitor that consists of a nasal pressure detector recording
the square root of pressure as an index of flow, thora-
coabdominal movement detection through two piezoelectric
belts, finger pulse oximeter, and body position detection. A
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comparative study against in-lab PSG using this device has
been performed in Dingli et al. [127] and in Ng et al. [128].
The Lifeshirt (Vivonoetics, USA) is a form-fitting vest
that comes with sensors embedded within which are capable
of monitoring a range of physiological parameters including
respiration via RIP, heart rate, oxygen saturation, and motor
activity [147, 148]. Thus it can be classified within the Type-3
category of portable devices. Analysis of ventilation through
RIP bands in the Lifeshirt is performed through a propriety
algorithm that computes breath volume and compares it
to the median breath volume of the preceding two-minute
interval. In the article published by Goodrich and Orr
[129], validation of autoscoring capabilities of the device was
compared against manual scoring of PSG. Manual editing of
the automatically generated results was allowed so that when
there was any discrepancy between the automated analysis
and the technician (e.g., due to artifact), the technician could
rescore part or all of the sleep study to make it more accurate.
Validation study of this device can also be found in the work
of Carter et al. [130].
The RUSleeping RTS (Philips Respironics, The Nether-
lands) is a Type-4 screening device with a single channel
that monitors changes in nasal pressure with a nasal cannula,
pressure transducer, and recording unit that provides signal
processing and data analysis [133]. The device monitors
changes in nasal pressure to detect respiratory events and it
calculates an index representing the number of these events
per hour of the overnight recording in real time [133]. More
details about the automatic scoring and the corresponding
validation results can be found in the work of Grover and
Pittman [133].
BreasSC20 (Breas Medical AB, Sweden) Type-3 system
consists of a four-channel device in which oxygen saturation
is measured by a flex sensor, and airflow is measured after
the square root transformation of the recorded nasal pressure
using a nasal cannula. From the nasal pressure, in addition,
the snoring signal is extracted. Thoracic and abdominal
movements in this device aremeasured independently by two
bandswith a piezoelectric crystal, which also keep track of the
body position [131]. Once the recording has been done, the
data is downloaded to PC software where the Breas Analysis
Software would provide indication of the presence of SAHS
and other associated disorders. For more details, the reader
is referred to the validation studies of Nu´n˜ez et al. [132] and
Ruiz-Lo´pez et al. [131].
The Stardust II (Philips Respironics, The Netherlands) is
a Type-3 portable monitor designed to measure and record
five diagnostic parameters: SpO
2
(via finger probe), pulse rate
(from the oximeter probe), airflow (pressure based airflow
through a nasal cannula), respiratory effort (piezoelectric
sensor in a belt placed midthorax), and body position (built-
in mercury switch) [149, 150]. Data collected is stored on
internal memory in the device and then downloaded to
a computer for automated analysis by the host software
(Stardust Host Software, Respironics, Inc., USA). Yin et
al. [134] evaluated the automatic scoring algorithm of this
device, however finding low agreement and suggesting that
data analysis should be performed manually.
6. Discussion
Throughout the previous sections the state of the art has been
reviewed comprising computer methods for the automatic
diagnosis of SAHS. The growing interest in the field of sleep
medicine, together with the recent advances in computer
analysis methods, have contributed to the increment of the
number of developments in the field in the last years. The
heterogeneity of the different techniques and the increment
of the scientific production make it somewhat difficult to
follow the trace of the recent developments in the area. This
situationmotivates a literature review to be performed whose
objective is to serve as a reference for the reader interested in
the development of computerized methods for the diagnosis
of SAHS. Specifically, the authors have focused on the analysis
of the research literature over the last 15 years.
A remark has to be done regarding the meaning of the
word diagnosis in the context of this review. In this respect,
diagnosis has to be rather interpreted as the capacity of
the computer method to intercept a well-defined severity
of AHI when the automatic analysis of the PSG is done.
Indeed it has to be taken into account that, according to
the last version of the AASM manual for the International
Classification of Sleep Disorders, formal diagnosis cannot
be based exclusively on the AHI, but, depending on the
resulting severity, diagnosis of SAHS may require the AHI to
be accompanied by additional symptomatology [9].
Taking the previous into account, analysis of the bib-
liography has effectively shown how the referred context
yet constitutes a field with a certain maturity, despite the
relative youth of the sleep science, where the number of
approximations has significantly increased, especially in the
last years. Even if the scope of the review has centered on
automatic methods that operate over the mostly extended
signals used in the clinical routine (see section VIII of the
AASM manual [6]) the resulting number of approaches is
noticeable. Actually, the reality is that such methods are yet
bypassing the research frontiers, and several solutions are
already present in the market (see Section 5). Acceptation of
these systems as well as their actual use in the real practice
still remains, however, somewhat low among the medical
specialists. It can be said, in fact, that implantation of the
computer-based SAHS diagnostic systems in the clinical
routine is still at a preliminary stage.
Complexity of the analysis task is undoubtedly playing a
role for this slow transfer. This complexity can be reflected
in the fact that many of the current available tools still
nowadays only partially fulfill some of the required subtasks
that integrate the whole diagnostic process. For example,
there exist SAHS diagnostic systems providing capabilities
for the analysis of the respiratory activity, which nevertheless
present deficiencies from the neurophysiological point of
view, and vice versa. In this review, this is noticeable, for
example, when examining the number of comprehensive
approaches in comparison with the rest of the methods.
Two concurrent trends may be differentiated by exam-
ining the previous literature review. On the one hand, the
first trend is focused toward reducing the required montage,
translating the complex full monitoring carried out in the
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attended hospital environment, to a more lightweight setting
which can be ultimately performed in unattended conditions,
even at the patient’s home. On the other hand, once the
recording has been done, and especially motivated by the
recent advances in the field of signal processing and artificial
intelligence, new analyzing algorithms are breaking through
with the purpose of automating the analysis of the resulting
data.
Certainly, and although somehow related, these two
trends can be considered separately. While reducing the
number of signals to be monitored has several advantages,
including reduction of costs, more comfort for the patient, or
reduction of waiting lists (more recordings can be scheduled
in parallel without being constrained by the number of beds
in the hospital), still manual scoring of the resulting data is
complex and time-consuming. For this purpose, automation
of the scoring process is still needed.
Throughout the analysis performed in Sections 4 and
5, Tables 1 to 9 are intended to serve as a quick reference
summarizing the different covered methods. In particular,
Tables 2, 4, 6, 8, and 9 are meant to hold validation details
of the different approaches for reference and comparison
purposes. Comparison of the results from one method to
another, however, is not always straightforward. First, it is well
known that usually validation results are heavily dependent
on the used database (demographics of the population,
number of subjects, balance of the classes, etc.) and on
the design of the validation tests. Some of these details are
included within the mentioned tables; however complete
coverage of all influencing factors would be unattainable.
Besides, it is worth recalling that values of sensitivity and
specificity reported in those tables (especially in Tables 2 and
9 where the validation results have strong dependency on
the selected AHI threshold) correspond always to the best
operation point of the method when using the automatic
analysis. Results in Tables 2, 4, 6, 8, and 9 can be therefore
regarded as optimistic and more in-depth analysis would
reveal that, in many cases, performance results are extremely
dependent on the experimental conditions. Variability in
the recording conditions, in the scoring criteria, or in the
validation metrics, makes it difficult to carry out objective
meaningful comparisons among the different methods. The
opinion of these authors is that validation results contained in
these tables should be considered for guidance only and that
they have to be carefully taken into account. The interested
reader is aimed at checking within each of the provided
references for more details.
Such a situation evidences the need to further standardize
the validation process in order to achieve more meaningful
comparisons among the differentmethods. A standardization
process like this would encourage the use of open and con-
sensus databases for which standard tests would be designed,
probably organized into different tasks. Each taskwould fulfill
specific necessities demanded from the clinical practice,
and, for each one, the proper validation process to assess
its degree of accomplishment would also be standardized.
Such a procedure, besides allowing more objective method
comparison, would set concrete objectives and would help
guide the development of future automatic analysis methods,
filling the gap between engineering research and clinical
necessities.
It is nonetheless undeniable that recent advances in
computer technology are already contributing and opening
new possibilities in the diagnosis of SAHS. Rapid screen-
ing of risk subjects is, for example, the main objective of
the methods analyzed throughout Section 4.1. Most of the
approaches analyzed in this respect (see Table 1) rely on the
analysis of a single channel, either by the monitoring of
the oxygen saturation or through some derived measure of
airflow. With respect to the first group (analysis of oxygen
saturation), results from Table 2 can be compared to those of
a previous review of Netzer et al. in 2001 [16] which reported
screening sensitivity and specificity varying, respectively,
between 41–100 and 31–98 for AHI cut-offs in the range of 10–
15. In the more recent review of Maurer [151], using similar
thresholds (5–15) screening sensitivities for these kinds of
methods ranged between 65–100 with specificities between
23–92. Looking at Table 2, our analysis reveals sensitivities
between 78–100 and specificities between 54.2–100 (76.7–100
and 70.8–100, resp., regarding methods using airflow). These
values, which have to be carefully interpreted for the reasons
already discussed, seem to nevertheless confirm a previously
reported trend in the literature (see also [151–156]) for which,
in general, screening methods for SAHS diagnosis tend to be
biased toward sensitivity.
Assessing validity of screening approaches, however, is
not an easy task, and in the case of OSAS some researchers
are raising the voice, for example, on the importance of
evaluating the results in the context of the prevalence of the
disease [157]. An additional problem to evaluate screening
approaches comes by the extended use of thresholds. Indeed
the problem has to do precisely with the absence of a
consensus to establish the appropriate limit value, causing
validity of these methods to differ upon the study sample and
the selected cut-off.
In contrast to screening and estimative approaches, detec-
tion approaches analyzed in Section 4.2 (see also Tables 3 and
4) involve the direct assessment of the associated severity for
which they seek individual detection of each single apneic
occurrence. Among them, some approaches can be found
that rely as well on the analysis of the oxygen saturation
signal. Indeed, because of its simplicity, relative robustness,
and easiness of registration, early there can be found several
computer approaches attempting apneic event localization
on the basis of this signal. Besides the methods analyzed
here, the works of Netzer et al. [16] and Flemons et al.
[42] include a good review of methods prior to the year
2000. A general limitation with the algorithms resulting from
the processing of the oxygen saturation is, however, the
incapacity to distinguish between apneas and hypopneas or to
carry out a classification of the detected event as obstructive,
central, or mixed.
Approaches carrying out the analysis of different res-
piratory channels such as nasal airflow, thoracoabdominal
respiratory movements, Pes, or FOT have been described
as well. These approaches may involve more complicated
techniques, but, as a result, more information about the
nature of the apneic event can be extracted. Within this
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group, approaches based on the analysis of single respiratory
channels are usually more prone to suffer from external
artifacts, especially those originated from the movement
of the patient. In general, more interesting approaches
can be obtained when the algorithm is implemented over
a multichannel environment, gathering information from
several cardiorespiratory derivations. These approximations
require dealing with the time correlation of the individual
events along the different channels, which complicates the
algorithm. On the contrary, multichannel approaches usually
lead to a more accurate detection of the apneic event and its
posterior classification. In particular, results in Table 4 show
that detection of apneas is relatively easier when compared
to hypopneas. This is not surprising for which an apnea
represents an event of bigger intensity which is easier to
identify in the PSG. Hypopneas, on the other hand, are
more subtle events, and even more the standard definition
for this kind of events has been historically a matter of
discussion [5, 41]. An excessive dependence on the use
of thresholds produces again negative consequences in the
detection context. For example, a common problem for the
analysis of the respiratory activity is the establishment of the
normal respiration baseline. In this context, the use of fixed
thresholds to identify amplitude changes in the respiratory
cycles may cause incorrect detection of several apneic event
occurrences. This is of special importance in cases with
subsequent repeated occurrences of airflow reductions—as
it is common in severe SAHS patients—and for the correct
detection of hypopnea events.
Dependency on the appropriate setting of thresholds or
critical values is indeed an issue shared by many of the
approaches analyzed in this review. It is a difficult question,
almost philosophical, because part of the problem actually
has to do also with the different approach followed by a
computer program and the human scorer when facing the
resolution of a decision problem. Indeed computer programs
usually carry out a discriminant analysis partitioning the out-
put space into disjoint sets (e.g., yes or no) leading to categor-
ical decisions and classifications. Human decision-making
processes, in contrast, usually serve the use of generalization
and approximation and are affected by uncertainty. Sleep
diagnosis is not an exception, and imprecision is inherent to
the domain and comes out of different sources. The presence
of noise in the signals, data dependency, redundancy, limited
sensitivity of the transducer, loss of information due to the
analog-to-digital conversion, interferences, or expert’s intra-
and intervariability are some examples. Moreover, it is usual
within the clinical language that opinions are given in terms
of possibilities rather than in certainties, possibilities over
which qualitative terms are used in contraposition to the
use of quantitative terms (and thus in contraposition to the
use of fixed numeric thresholds). Given this context, the
necessity of building systems emerges that are able to handle
heuristic knowledge and vague expressions and to carry out
the decision-making from a qualitative point of view. Recent
developments in artificial intelligence and signal analysismay
play an important role and become part of the solution to this
problem.
Classification of the detected events as obstructive, cen-
tral, ormixed represents a further step in the diagnosis and an
additional challenge for the automatic scoring program.This
review has analyzed several methods in this respect which are
summarized in Tables 5 and 6. According to results in Table 6,
it seems that discrimination of mixed events represents the
most difficult task. Only in the work of Reisch et al. [46],
this class has been the most accurately detected. However,
this holds only when either the Pes (which is invasive) or
the FOT signals are used, both of them rarely used in the
clinical practice. In addition, it has to be considered that the
definition of mixed events is also controversial for manual
scoring [158] and thus scoring of these events is expected to
be specially affected by interscorer variability.
Comprehensive approaches represent an alternative view.
Methods analyzed within this category do not involve the
simplification of the monitoring montage. In contrast to
previous approaches, it is their aim to help the clinician,
saving time and reducing the complexity of the PSG analysis,
however, while respecting the full standard scoring proce-
dures as much as possible.
Development of comprehensive approaches therefore
represents a great challenge from the perspective of soft-
ware engineering. Computer analysis of a full-night PSG
involves a considerable amount of data to be processed, in
which information has to be meaningfully correlated in time
among the different channels to detect patterns of clinical
relevance.The processing of several PSG channels implies the
application of different analysis methods in order to extract
the respective events of interest. Artifacts and interactions
among the whole set of derivations have to be carefully taken
into account. Moreover, for a system to be regarded as a
supporting tool to aid in clinical decision, it is desirable that
it provides interpretable outputs. The previous necessarily
involves accepted medical knowledge to be implemented in
form of heuristic rules, which make knowledge of the system
explicitly available to the physician. Tracing of the reasoning
processes and follow-up of the diagnostic procedure should
be enabled in the system.
In this respect, and from a software engineering perspec-
tive, it seems that while signal processing methods are more
useful to extract the relevant information from the patient’s
biosignals, artificial intelligence techniques are more suitable
for the analysis and interpretation of the extracted features.
Specifically, for the analysis and interpretation of the sym-
bolic events, knowledge-intensive approaches are preferred
in contraposition to data-driven approximations. Effectively,
although higher precision can be achieved with the use of
data-intensive approaches such as SVMs or neural networks,
a problem is the absence of any explanation capabilities of
the results. Indeed, from the user perspective, these methods
ultimately behave as black-boxes.
A survey of validation studies regarding commercial
approaches has been performed throughout Section 5 and
summary results are contained in Table 9. The analysis
reflected the growing interest toward the design of portable
devices for outpatient (in-home) monitoring. Out of 28
studies, only 3 referred to validation of Type-1 devices, while,
from the remaining 25, 13 dealt with validation of Type-3
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devices and 12 of Type-4 devices. However, from the same
25 regarding portable devices, only 9 did actually contain
data from in-home monitoring. Of them, 6 performed a
comparison between different-night in-home and Type-1 in-
lab registrations, 1 used same-night Type-2 monitoring as
reference, and 2 used same-night Type-3 registrations.
Sensitivities and specificities on the 6 studies with
different-night comparison of in-home monitoring with
Type-1 registrations varied between 92–100 and 50–100,
respectively, in the case of in-lab conditions and between
79.4–100 and 76.5–100 in the case of home monitoring.Thus,
although common sense dictates that in-home registration
may introduce additional sources of noise and unreliability
in the automatic scoring, it is difficult to extract such
conclusions from the results of Table 9. It has be beard in
mind, though, that these results are expected to be affected
at least by internight and interstudy variability. Results are
not conclusive when we eliminate the interstudy factor and
we look at the individual results for each study. On the other
hand, some studies in literature have also suggested that
reliability of in-home recordings, when manual scoring is
performed by trained technicians, is similar to that achieved
on attended in-lab conditions [159, 160]. Unfortunately, none
of the studies have tried tomake a comparison between same-
night in-lab registration and same-night in-home registration
using the same system. Such a study would have shown
interesting data on whether the recording conditions could
have a true significant influence on the performance of the
automatic scoring.
Nonetheless, and although portable devices may not
offer the full functionality of the comprehensive approaches,
they have the great advantage of allowing the patient to
be monitored at home. A screening diagnosis can then be
issued, serving as first alert or control, and be used for
triage reducing dependence from the hospital resources.
That means reducing of waiting times, reducing costs, and
increasing the number of diagnoses. The reduced cost of
in-home studies in comparison to those carried out at the
hospital has been even reported in a study byGolpe et al. [161]
under the condition that a supporting technician would be
required to attend to patient’s home. Usually, however, this
is not even necessary since the patient can be prepared for
home monitoring at the sleeping center by trained staff. The
trend is in fact toward the increment of portable monitoring,
a practice with an increasing role (although not yet decisive
[42, 162]), with growing support from scientific societies,
and is already included in the clinical routine of many sleep
centers worldwide.
Integration of portable devices into an intelligent tele-
monitoring platform would be the next step, according to
the authors, in the development and expansion of portable
sleep monitoring. Such a platform would allow the medical
staff to increase the monitoring by remote follow-up of the
patient. Indeed, due to the high costs associated with the
in-hospital PSG, current diagnosis is usually constrained to
data from limited, if not just only one-night, registration.
This represents a major limitation for current sleep studies
which may bias the diagnosis, especially in the cases where
the disease does not manifest every night (e.g., as in the
case of some sleep parasomnias). Discussion is over the table
in the medical field about second-night effects, or whether
monitoring of the patient out of his/her normal sleeping
environment—as done in in-hospital night monitoring—
accurately reflects or can instead influence the actual sleep-
ing pattern. It seems reasonable to believe, though, that
an increment in the number of monitored nights would
contribute to getting rid of the one-night bias effect and
help to come up with a better diagnosis. Integration of
portable devices into an intelligent telemonitoring platform
would permit, in this respect, lowering the cost and allow
more periodic patient monitoring to be performed. The
term intelligent is important, however, because increased
monitoring ultimately means increased amount of data to be
analyzed, and therefore eventually some kind of automatic
analysis must be introduced in the process for it to be
scalable.
7. Conclusions
The number of contributions regarding computer-assisted
diagnosis of SAHS within the last 15 years is prominent.
Despite the relative youth of the sleep medicine, analysis of
the state of the art has effectively shown how the referred
context yet constitutes a field with a certain maturity. Sev-
eral methods have been analyzed which focus on different
subtasks of the diagnostic process, from the screening and
early diagnosis to full comprehensive systems. Indeed, nowa-
days computer-assisted SAHS diagnostic systems are already
bypassing the researching frontiers with several solutions
currently present in the market. The actual use of the
full automatic scoring possibilities of these systems in real
practice, however, still remains low.
Current efforts in the design of these systems are focusing
on the design of robust algorithms which can be used to
accurately interpret data registered in ambulatory condi-
tions. This should contribute to unlocking the bottleneck of
the centralized in-hospital diagnosis and reduce the costs
associated with the test. Development of full comprehensive
approaches to handle the analysis of the full PSG is also
desirable to help the clinician with the time-consuming
scoring task. These approaches may also contribute to reveal
new data and patterns of relevance to improve the diagnosis.
Some aspects to be improved within the current available
approaches have to deal with the excessive sensitivity to
the presence of artifacts and noise, the difficulty to handle
variability present in the signals, excessive dependence on
thresholds, lack of explanation of their results, or the bias
due to patient dependency and human subjectivity. Recent
developments in artificial intelligence and signal analysismay
play an important role in the future development of SAHS
diagnostic systems.
Further testing is also needed. To correctly assess the
actual capabilities of the current approaches, validation has
to be extended to increase the patient’s sample, involve more
heterogeneous cases, and make use of standard databases.
Standardization of the validation process should be assessed
aswell in order to allowmeaningful comparison of the results.
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